PIPELINE WATCH Basiliximab loses SPC protection in the EU pril brings the expiry of supplementary protection certificates (SPCs) for Novartis’ monoclonal antibody (mAb) Simulect (basiliximab) in major European Union (

First Page		Document Content
Date: 2013-04-23 21:06:39		PIPELINE WATCH Basiliximab loses SPC protection in the EU pril brings the expiry of supplementary protection certificates (SPCs) for Novartis’ monoclonal antibody (mAb) Simulect (basiliximab) in major European Union ( Add to Reading List Source URL: www.genericsweb.com Download Document from Source Website File Size: 49,68 KB Share Document on Facebook